医疗技术产品销售收入产品创新波士顿科学国际有限公司是一家全球性的医疗技术产品研发,生产,营销公司,现有17,500名雇员,2005年的销售收入为63亿美金.在过去的二十五年中,公司为广泛的医疗技术领域提供了具有深度和广度的众多创新产品,从而推动了微创介入产品的实践和发展.通过提供传统外科手术的替代产品,波士顿科学公司致力...
But Roche still went ahead and bought an unprofitable company for $1 billion in a transaction reminiscent of its purchase of a controlling stake in Genentech in 1990. Aside from the deal structures, which in both cases leave the US management team intact if now reporting to Roche HQ in Basel...
Claims inherently linking race, nationality and intelligence have long played a role in scientific racism, which uses pseudoscience to try to justify false claims of racial inferiority or superiority. And intelligence quotient testing, a commonly used measure of intelligence, has long been criticized as...
The article reports on clinical data on new orthopedics products released by Boston Scientific. Such data include results to two studies that evaluated the Infinion 16 Percutaneous Lead for spinal cord stimulation (SCS) therapy and the Clik Anchor locking system. Doctor Timothy Chafin, lead author ...
Boston Scientific Announces Submission of First Module of PMA Application for its TAXUS™ Paclitaxel‐Eluting Coronary Stent SystemJournal of Clinical Engineering
Boston Scientific to Pay $1.7 Billion Settlementdoi:10.1097/01.BMSAS.0000369816.85000.05Biomedical Safety & Standards
Focuses on the ruling of a District Court jury in Wilmington, Delaware, on the patent infringement case between Johnson & Johnson (J&J) and Boston Scientific Corp. Why the jury ruled that J&J's patent relating to stents was both valid and infringed by Boston Scientific's NIR stents; Reaction...